Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026)

Tyra Biosciences' Capital Expenditures history runs 7 years deep, the most recent figure standing at $88000.0 for Q1 2026.

• Quarterly Capital Expenditures changed N/A year-over-year to $88000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156000.0 (down 70.45% YoY) and the FY2025 annual result came in at $68000.0, down 89.76% from the prior year.
• Capital Expenditures was $88000.0 for Q1 2026 at Tyra Biosciences, up from $43000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $624000.0 in Q3 2024 and bottomed at -$210000.0 in Q2 2022.
• A 5-year average of $106000.0 and a median of $45000.0 in 2025 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 418.18% — and 2023, when it surged 6800.0%.
• Tyra Biosciences' Capital Expenditures stood at -$9000.0 in 2022, then jumped by 6800.0% to $603000.0 in 2023, then plunged by 99.0% to $6000.0 in 2024, then soared by 616.67% to $43000.0 in 2025, then jumped by 104.65% to $88000.0 in 2026.
• Business Quant data shows TYRA's Capital Expenditures at $88000.0 in Q1 2026, $43000.0 in Q4 2025, and -$20000.0 in Q3 2025.